Florida Dermatology Billing: The Vendor Evaluation Questions That Reveal CO-50 Defense and Mohs Billing Capability

-

Choosing a medical billing or RCM vendor for a Florida dermatology practice requires more than comparing collection percentages and monthly fees. Dermatology billing has specialty-specific risks, particularly when a practice performs Mohs micrographic surgery, pathology-related services, biopsies, and other procedures where documentation, medical necessity, coding, and payer policies directly affect reimbursement.

One important area to examine is the vendor's ability to prevent and defend CO-50 denials.

CARC 50 indicates that a service was considered non-covered because the payer did not determine it to be medically necessary. CMS guidance also shows that CO-50 can be used following medical review when a payer determines that coverage requirements have not been met.

For a Florida dermatology practice, the vendor evaluation process should therefore go beyond asking, "How much do you collect?"

The better question is: "How do you protect our revenue when a payer challenges medical necessity or Mohs documentation?"

Why CO-50 Defense Matters in Dermatology Billing

A CO-50 denial can represent more than a simple coding issue.

When a payer questions medical necessity, the billing team may need to determine whether the claim was supported by the diagnosis, documentation, coverage policy, procedure performed, and other claim information.

A capable dermatology billing vendor should have a defined process for identifying the reason behind the denial before submitting an appeal.

The team should be able to distinguish between a true medical-necessity issue, a documentation gap, an incorrect diagnosis code, a payer policy issue, and a claim submission error.

This distinction matters because simply resubmitting the same claim does not solve the underlying problem.

Question #1: How Do You Analyze CO-50 Denials?

Ask a prospective billing vendor:

"When our claims receive CO-50, how do you determine whether the denial is appealable?"

A strong answer should involve more than saying that the team will "work the denial."

The vendor should explain how its team reviews the remittance advice, payer policy, diagnosis codes, procedure codes, clinical documentation, and other available information to identify the actual denial reason.

The vendor should also be able to report CO-50 activity by payer, provider, procedure, diagnosis, and root cause.

This allows the practice to determine whether CO-50 denials are isolated incidents or part of a recurring reimbursement problem.

Question #2: Can You Handle Mohs Micrographic Surgery Billing?

Mohs billing requires specialized knowledge.

CMS coverage guidance states that medical records should clearly support why Mohs surgery was selected based on factors such as complexity, poorly defined borders, possible deep invasion, prior irradiation, size, or location where tissue conservation is important.

Ask the vendor:

"How does your team validate Mohs claims before submission?"

The answer should address diagnosis-to-procedure alignment, documentation requirements, payer-specific coverage policies, appropriate CPT reporting, and claim-level review.

A vendor that primarily handles routine office visits may not have the same level of expertise required for a dermatology practice with a significant Mohs surgery volume.

Question #3: Does Your Team Understand Mohs Pathology Rules?

This is another important evaluation question.

CMS guidance states that reporting Mohs CPT codes 17311–17315 together with surgical pathology codes for tissue used in margin evaluation during Mohs surgery is inappropriate. Such claims may be denied. Separate pathology may be appropriate in certain circumstances when tissue is distinct from the tissue examined during Mohs, but the record must clearly support the reason for the additional pathology service.

Ask:

"How do you prevent incorrect billing of Mohs and pathology services?"

A knowledgeable vendor should be able to explain how its coding team distinguishes tissue examined during Mohs from separate specimens and how documentation is reviewed before billing.

This is the type of technical question that can quickly reveal whether a vendor actually understands dermatology billing.

Question #4: How Do You Track Mohs Denials?

Do not accept a general denial report that combines every dermatology service into one category.

Ask for a specific answer:

"Can you show us how you would report Mohs denials separately from other dermatology denials?"

A useful reporting structure should help the practice identify patterns such as repeated medical-necessity denials, diagnosis-related denials, documentation issues, coding problems, and payer-specific trends.

The objective is not simply to recover individual denied claims.

The objective is to reduce the number of preventable denials entering the system.

Question #5: How Do You Use Payer Policies Before Claims Are Submitted?

Payer policies can affect whether dermatology procedures are reimbursed.

A vendor should have a process for monitoring applicable coverage policies and incorporating relevant requirements into coding and claim review.

This becomes particularly important for Mohs surgery because Medicare coverage policies can specify covered indications, diagnosis requirements, documentation requirements, and other conditions for reimbursement. CMS's current Mohs billing article was updated in July 2026, demonstrating why practices need a process for keeping billing knowledge current.

Ask the vendor:

"How do you keep your dermatology billing team current when payer policies change?"

The response should identify an actual process rather than simply saying that the team receives "regular training."

Question #6: Who Handles the Appeal?

Another critical question is:

"Who actually works our CO-50 appeals?"

Find out whether appeals are handled by general billing staff or by employees with dermatology billing and coding experience.

Ask how the team gathers supporting documentation, reviews the payer's reason for denial, prepares the appeal, tracks deadlines, and follows up with the payer.

Also ask whether the practice receives reporting on appeal outcomes.

A vendor should be able to show whether its appeals are producing recoveries and which denial categories are most successfully overturned.

Question #7: Can You Show Us a Dermatology-Specific Dashboard?

A dermatology practice should not have to rely on a generic RCM dashboard.

Ask whether the vendor can report:

  • CO-50 denial volume
  • Mohs denial rate
  • Appeal recovery rate
  • A/R by aging category
  • Payer-specific denial trends
  • Underpayments
  • Clean claim performance
  • Days in A/R
  • Net collections
  • High-value procedure performance

The exact metrics can vary by practice, but the dashboard should help administrators connect billing activity with financial performance.

Question #8: What Happens Before a High-Value Mohs Claim Is Submitted?

This question can reveal the vendor's real operating model.

Ask:

"What pre-billing checks are performed on a Mohs claim?"

The vendor should be able to explain how it verifies the claim information and identifies potential problems before submission.

Prevention is generally more efficient than waiting for a payer to issue a denial and then beginning the recovery process.

This is particularly important when a practice performs a high volume of procedures where one recurring billing error can affect many claims.

Question #9: Can You Analyze Our Existing Aged A/R?

When evaluating a new RCM vendor, do not focus exclusively on future claims.

Ask the vendor to review existing aged receivables.

A good evaluation should identify whether older dermatology claims contain recoverable revenue, including denied claims, underpayments, unresolved payer issues, and claims approaching filing or appeal deadlines.

For Florida dermatology practices considering a vendor change, Florida Dermatology Practices Switching RCM Vendors provides additional considerations for evaluating an RCM transition.

Question #10: How Will You Protect Revenue During an RCM Transition?

Switching billing vendors creates its own financial risk.

Ask the prospective vendor how it will manage open claims, pending denials, aged A/R, payer follow-up, reporting, credentials, clearinghouse processes, and data transfer during the transition.

The objective should be continuity.

Claims should continue moving through the revenue cycle while the new vendor takes ownership of the account.

A transition plan should also establish responsibility for existing A/R rather than leaving older claims behind with the previous vendor.

For additional guidance, see Dermatology Practices Switching RCM Vendors Before Year-End.

The Best Vendor Is Not Simply the One With the Highest Collection Rate

A high collection percentage can look impressive, but it does not tell the entire story.

A dermatology practice should also understand how much revenue is being lost before collection, how effectively denials are prevented, how quickly claims are submitted, how accurately Mohs procedures are coded, and whether underpayments are identified.

The vendor evaluation should therefore focus on revenue protection, not just revenue collection.

A billing partner that understands CO-50 denial patterns, Mohs documentation requirements, payer policies, appeals, underpayments, and aged A/R can provide significantly more value than a vendor that simply submits claims and posts payments.

Final Thoughts

For Florida dermatology practices, evaluating an RCM vendor requires specialty-specific questions.

CO-50 defense and Mohs billing capability are two areas where a vendor's actual expertise can become visible very quickly.

Ask the right questions before signing a contract. Request examples of denial reporting, understand the vendor's Mohs coding workflow, ask how medical-necessity denials are appealed, and determine how aged A/R will be handled during and after the transition.

The goal is simple: choose a billing partner that can help prevent avoidable revenue loss before it becomes an accounts receivable problem.

Location: Florida, USA

Comments

Post a Comment

Popular posts from this blog

Is Your Neurology Billing Outsourcing Helping or Hurting You at Year-End?

-
Image
  As year-end approaches, neurology practices face a crucial decision: Is your billing outsourcing truly improving your financial performance, or silently affecting your revenue? Neurology billing is complex due to time-based coding, modifier usage, high documentation requirements, frequent audits, and prior authorization challenges. If your billing partner lacks neurology-specific expertise, it may lead to claim denials, revenue loss, and compliance risks. Signs Your Neurology Billing Outsourcing Is Helping If your billing partner is performing well, you will see: • Reduced denial rates for neurology codes (EEG, EMG, Botox, Nerve Conduction Studies) • Faster reimbursements and fewer delays from payers • Active recovery of old AR beyond 60, 90, or 120+ days • Accurate CPT, ICD-10, and modifier usage for neurology procedures • Clear billing reports, denial analysis, and revenue insights • Compliance with Medicare, commercial payers, and documentation standards Warning ...
Read more

How Hidden OB-GYN Billing Errors Are Quietly Costing You Millions Each Year

-
Image
  The Silent Revenue Leak in OB-GYN Practices Most OB-GYN practices don’t realize they’re bleeding money. Not in dramatic, headline-grabbing ways, but quietly, steadily, month after month. The phones are ringing, appointment slots are full, deliveries are happening, and yet the numbers never seem to match the effort. Sound familiar? This is often the first sign of hidden OB-GYN billing errors working behind the scenes. These errors don’t announce themselves. They don’t crash your systems or send angry alerts. Instead, they slip through claims, hide in coding nuances, and quietly shave thousands—or millions—off your annual revenue. OB-GYN billing is uniquely complex compared to other specialties. Between global maternity packages, split billing scenarios, high-risk pregnancy coding, and ever-changing payer rules, the margin for error is enormous. A single missed modifier or incorrectly bundled service might seem insignificant on its own. But when repeated across hundreds or thousand...
Read more

The #1 Reason ASCs Lose Revenue from Medicare Claims (And How to Fix It)

-
Image
Ambulatory Surgical Centers don’t lose Medicare revenue because of low case volume. They lose it because of one recurring, preventable failure: Incorrect coding and documentation for Medicare’s ASC-specific payment rules. This single issue triggers denials, underpayments, delayed reimbursement, and permanent write-offs — especially at year-end. If your ASC’s Medicare revenue feels unpredictable, this is why. The #1 Revenue Killer: Not Billing Medicare the “ASC Way” Medicare does not treat ASCs like hospitals or physician offices. Yet many ASCs still: Use hospital-style assumptions Miss ASC-only payment rules Underestimate Medicare’s bundling logic The result? Claims get paid less than expected — or not at all. Where Medicare ASC Claims Go Wrong 1. Incorrect CPT eligibility for ASC payment Not every CPT code is payable in an ASC setting under Medicare. Common mistakes: Billing procedures not on Medicare’s ASC approved list Assuming “covered in hospital” = “covered in ASC” Missing annual...
Read more